VYOME HOLDINGS, INC. Stock Split Ratio
VYOME HOLDINGS, INC. (HIND) had Stock Split Ratio of 4.00% as of 2025-05-09, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-08-14
- 2025-05-09: Stockholders' Equity Note, Stock Split, Conversion Ratio 4.00%.
- 2024-09-23: Stockholders' Equity Note, Stock Split, Conversion Ratio 1.72%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 1.70%.
- 2022-12-23: Stockholders' Equity Note, Stock Split, Conversion Ratio 2.00%.
- 2021-06-15: Stockholders' Equity Note, Stock Split, Conversion Ratio 33.30%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month |
|---|---|---|---|---|
| 2025-05-09 | 4.00% 10-Q · filed 2025-08-14 | |||
| 2024-09-23 | 1.72% 10-Q · filed 2025-08-14 | 1.70% 10-Q · filed 2024-11-14 | ||
| 2022-12-23 | 2.00% 10-K · filed 2024-04-01 | |||
| 2021-06-15 | 33.30% 10-K · filed 2023-04-17 | |||
| 2019-07-24 | 1.00% 10-K · filed 2021-03-12 | 10.00% 10-Q · filed 2019-11-08 | ||
| 2016-09-30 | 34.48% 10-K · filed 2018-03-05 | 34.48% 10-Q · filed 2016-11-10 | ||
| 2014-02-28 | 33.30% 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |